The recombinant prostate-specific PPT sequence comprises a prostate-specific antigen enhancer, a PSMA enhancer and a TARP promoter. It is transcriptionally active in human prostate cancer cells both ...
Prostate cancer is the most common cancer among men in Europe and the United States, and the third most common cancer among men in the world. 1 The current therapies for localized prostate cancer are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results